Skip to main content
Caplight Logo









Cellestetix

Cellestetix

Private
TurkeyHealthcare & Life Scienceshttps://cellestetix.com/

Last Round

Seed

Aug 16, 2024

Total Funding Raised

$2M

Company Overview

Cellestetix is a biotechnology company that specializes in the research, development, and commercialization of plant-based exosome formulations for regenerative beauty and wellness applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, D2C Brands

Business Model

B2C

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

exosome technologyplant-based exosomesregenerative beautybiotech skincarecosmetic formulationbiohacking beautyvegan skincarebiotechnologyd2c skincareskin regenerationb2b biotechclean beautymolecular signaling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellestetix Comparables

Compare Cellestetix with similar companies based on industry and business-model similarity.

Cellestetix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exoceuticals
81%
Arcaea
77%
OneSkin
77%

Cellestetix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 16, 2024

Cellestetix Investors

Notable investors and investment history

Cellestetix investors
InvestorRounds
Maxis VenturesSeed
ISTCAPITALSeed
APY VenturesSeed
Pragma Capital PartnersSeed
Arya VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2024

    $2M raised from APY Ventures, ISTCAPITAL, and others.

Cellestetix Filings

Explore SEC and related filing metadata, where available.

Cellestetix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellestetix's valuation, stock price, and market status.

Is Cellestetix a public or private company?

Cellestetix is a private company.

What is the current stock price of Cellestetix?

Cellestetix is a private company with no public stock price. Caplight tracks Cellestetix's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Cellestetix worth (valuation)?

Valuation information for Cellestetix is not publicly available.

Can I buy Cellestetix stock?

Cellestetix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellestetix's last funding round?

Cellestetix's most recent funding round was Seed on August 16, 2024.

Who are the main investors in Cellestetix?

Key investors in Cellestetix include Maxis Ventures, ISTCAPITAL, APY Ventures, Pragma Capital Partners, Arya VC.

Will Cellestetix IPO soon?

No public IPO plans have been announced for Cellestetix.

How can I track Cellestetix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellestetix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTurkey
Year Founded2023
Last FundingAug 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?